Blockchain Registration Transaction Record

Oncotelic Launches AI-Powered GMP Platform to Tackle Biotech Manufacturing Bottleneck

Oncotelic Therapeutics launches AI-powered GMP manufacturing platform for biotechs, integrating PDAOAI, digital batch records, and robotics to overcome manufacturing bottlenecks.

This news matters because it addresses a critical barrier in drug development: manufacturing. For many small biotechs and startups, the inability to access affordable, compliant GMP manufacturing can stall or kill promising therapies. Oncotelic's AI-GMP platform democratizes access to high-quality manufacturing, potentially accelerating the delivery of new treatments for cancer and other serious diseases. It also showcases how AI and robotics can transform pharmaceutical production, making it faster, cheaper, and more reliable—benefits that ultimately translate to better patient outcomes.